Aspire Healthcare Pharma (India) Private Limited, a active foreign private limited company, was established on 12 March 2019 in Chennai, Tamil Nadu, India. Engaging in infrastructure project management within the professional, scientific and technical sector, it holds CIN: U74999TN2019FTC127980. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Formerly known as Morningside Healthcare (India) Private Limited. Employing 54 professional, Its leadership includes Murali Raman (Director), Gary David Buckley (Director), Richard Michael Condon (Director). Past directors included Danesh Vinodkumar Gadhia, Gary David Buckley, Ian Brace. Its latest AGM occurred on 24 September 2025, with the balance sheet filed on 31 March 2025. It is based at The Executive Center, Level 5, Prestige Palladium,, Bayan No 129-140,, Chennai, Tamil Nadu, 600006.
U74999TN2019FTC127980
127980
12 March 2019
₹1.00 M
₹1.00 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Aspire Healthcare Pharma (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Murali Raman | Director | 12 Mar 2019 | Current |
| Gary David Buckley | Director | 26 Jul 2023 | Current |
| Richard Michael Condon | Director | 06 Jan 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Additional Director | 26 Jul 2023 | Past |
| Pramod Abcsdd | Additional Director | 25 Jul 2023 | Past |
| Pramod Abcsdd | Director | 01 Oct 2022 | Past |
| Pramod Abcsdd | Additional Director | 25 Jul 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aspire Healthcare Pharma (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 110.07% increase. The company also saw a substantial improvement in profitability, with a 122.57% increase in profit. The company's net worth Soared by an impressive increase of 159.86%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Aspire Healthcare Pharma (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Aspire Healthcare Pharma (India) has a workforce of 54 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aspire Healthcare Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aspire Healthcare Pharma (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Aspire Healthcare Pharma (India) Private Limited last Annual general meeting of members was held on 24 Sep 2025 as per latest MCA records. was completed.
Progress on Aspire Healthcare Pharma (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was documented.
Progress on Gary David Buckley was appointed as a Director was appointed as a Director on 26 Jul 2023 & has been associated with this company since 2 years 4 months . was documented.
Progress on Richard Michael Condon was appointed as a Director was appointed as a Director on 06 Jan 2023 & has been associated with this company since 2 years 11 months . was documented.
Progress on Murali Raman was appointed as a Director was appointed as a Director on 12 Mar 2019 & has been associated with this company since 6 years 9 months . was documented.
The activity Aspire Healthcare Pharma (India) Private Limited was registered on 12 Mar 2019 with Roc Chennai & aged 6 years 9 months as per MCA records. was completed.
The CIN of Aspire Healthcare Pharma (India) Private Limited is U74999TN2019FTC127980.
Aspire Healthcare Pharma (India) Private Limited is headquartered at The Executive Center, Level 5, Prestige Palladium,, Bayan No 129-140,, Chennai, Tamil Nadu, 600006.
Aspire Healthcare Pharma (India) Private Limited was incorporated on 12 March 2019.
The current directors of Aspire Healthcare Pharma (India) Private Limited are
The primary industry of Aspire Healthcare Pharma (India) Private Limited is Professional, Scientific And Technical.
Aspire Healthcare Pharma (India) Private Limited is unlisted.
The authorized capital of Aspire Healthcare Pharma (India) Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
_PRIVATE_LIMITED.webp)
Company Details
+91-XXXXXXXXXX